RSS

stem cell therapy

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

UK-based developer of cell-based therapeutics, ReNeuron Group, has won a grant to advance the development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina. Read more

News

The first allogenic stem cell therapy — Alofisel (darvadstrocel) from TiGenix and Takeda Pharmaceutical Company — has received marketing authorisation approval from the EC for the treatment of complex perianal fistulas in Crohn’s disease Read more

News

Orchard Therapeutics, a clinical-stage biotechnology company, has acquired an exclusive licence to develop lentivirus-based autologous ex-vivo gene therapy for Sanfilippo syndrome type B (or MPS-IIIB) from The University of Manchester. Read more

News

A number of obstacles remain before stem cell therapies become widely commercially viable, according to business intelligence provider GBI Research. Read more

News

Aston University has been awarded £4.7m (€6m) to develop Autostem, a robotic stem cell factory Read more

News

Frost & Sullivan is to host a webinar on stem cell therapy pipeline and treatments innovating regenerative medicine Read more

News